[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f3mweMVCgUT5tAL50aDz6-R33tCTDWxykzt-W5tUQSC4":8,"$fvWVtJP0uh4pvADAlu56eGc-yJMC0e3ZE9V0kiI1z4t4":55,"$f_-iAEcbS_F0ChzfaNvKE1MWaIm_J5N1tVbw4pxcie0s":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},74015,867332,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//NaWaskW0OJ0kWUt2Jjayxy1WaVEph7oE.png","宋阳","新乡医学院第一附属医院","普外科","住院医师",71,0,"乳腺癌 pT2N0M0 治疗方案常用药品：安全用药细节全解析","","https://ystcdn.venuertc.com/venue/AI/645d770a-e349-4c67-b7ae-33be418b1e6e.jpg","\u003Cdiv class=\"material-guide\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">乳腺癌 pT2N0M0 治疗方案常用药品：安全用药细节全解析\u003C/h1>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#f7f3fc 50%,#e3ecf7 100%);\">\n    \u003Ch2 class=\"material-subtitle\">01. 药品类别与主要用途 🌱\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      在乳腺癌 pT2N0M0 治疗中，通常涉及三类核心药品：辅助化疗药物、内分泌治疗药物以及靶向治疗药物。这些药物各自发挥不同作用，有的阻断肿瘤细胞生长，有的通过调节激素水平来干预，有的则针对特定的肿瘤相关靶点。本文将带您逐条梳理6个常见关键用药细节，助力科学安全地使用这些药品，降低不良反应风险，提升疗效。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#f4faf2 50%,#f7f3fa 100%);\">\n    \u003Ch2 class=\"material-subtitle\">02. 化疗药物的正确使用方法与注意事项 💉\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>常用药品：\u003C/strong>多柔比星（Doxorubicin）、环磷酰胺（Cyclophosphamide）、紫杉醇（Paclitaxel）为主流辅助化疗药物。通常采用静脉输注剂型，需在有资质医疗机构由专业人员操作。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>服用/使用时间：\u003C/strong>化疗方案由医生依据周期制定，一般间隔 2-3 周一次，每次持续数小时不等，不建议随意调整给药频率。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>剂量与配伍：\u003C/strong>剂量需按体表面积精确计算，切勿擅自增减。部分药物需避免与特定溶液混合，如多柔比星不可与碱性药剂共用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>常见副作用：\u003C/strong>脱发、恶心呕吐、骨髓抑制等较常见。发生不良反应时不宜自行停药，应联系医生调整方案。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药物相互作用：\u003C/strong>化疗期间，常见的相互作用包括与某些抗生素、免疫抑制剂、肝酶诱导剂/抑制剂。如紫杉醇与强效酮类药物同用时，需警惕药物代谢的影响。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>储存方法：\u003C/strong>未开封时需置于阴凉避光处（2-8°C），不可冷冻；开瓶后尽快用完。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>实际用药案例：\u003C/strong>\n          临床上曾有患者在多柔比星和紫杉醇联合治疗时未注意补液间隔，出现暂时性不适，经调整输注顺序后症状缓解，凸显专业监护重要性。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#f5f8fd 55%,#fcf3f7 100%);\">\n    \u003Ch2 class=\"material-subtitle\">03. 内分泌治疗药物的安全使用 📅\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>代表药品：\u003C/strong>他莫昔芬（Tamoxifen）、来曲唑（Letrozole）、阿那曲唑（Anastrozole）。适用于激素受体阳性人群，具体药品需由医生判定。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>剂型与服用方法：\u003C/strong>他莫昔芬、来曲唑、阿那曲唑均为口服片剂。服用时可选每日固定时间，用温开水吞服，建议餐后服用以减少胃肠刺激。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>用药持续时间：\u003C/strong>通常单药长期服用，周期可达 5 年或更久，需遵循医嘱，切忌自行中断。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>常见副作用：\u003C/strong>如潮热、关节痛、疲乏感等。出现严重不适时建议及时就医评估，严禁自行加减剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药物相互作用：\u003C/strong>激素抑制类药品与华法林、若干抗抑郁药物等可能发生代谢竞争，影响药效或安全性，需避开同服或间隔服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>禁忌与特殊人群：\u003C/strong>孕妇、哺乳期妇女慎用或禁用；有严重肝功能不良者用药前须严格评估。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>小贴士：\u003C/strong>\n          原则上服药时间保持规律，可设闹钟提醒自己，减少漏服。漏服时切勿双倍补服，下次按常规时间继续即可。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>用药案例补充：\u003C/strong>\n          一位正在服用来曲唑的女士反映关节不适，经与医生沟通调整用药时间与运动量，有效减轻不适，提醒耐心沟通、定期随访的重要性。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#f1f7f5 40%,#faf5fa 100%);\">\n    \u003Ch2 class=\"material-subtitle\">04. 靶向治疗药物的关键应用细节 🎯\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>常用药物：\u003C/strong>曲妥珠单抗（Trastuzumab）、帕妥珠单抗（Pertuzumab）等，用于 HER2 靶点相关治疗。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>剂型与给药方式：\u003C/strong>主要为静脉注射，部分地区已上市皮下注射剂型。但需专业人员严格按照药品说明书执行。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>给药周期：\u003C/strong>初始剂量和维持剂量均有明确指引，一般每三周注射一次。漏服需尽快与医生沟通，不宜自行补充。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>常见副作用：\u003C/strong>静脉炎、短暂性过敏反应、轻度心功能波动等。首次使用建议密切观察，发现异常立即就医。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药物相互作用：\u003C/strong>与蒽环类等其他化疗药物合用时，可能增加心脏毒性的发生率。常规建议不与心脏毒性药物同日给予。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>储存和管理：\u003C/strong>曲妥珠单抗应冷藏（2-8°C），避免冻存，配制后勿长时间放置。药品启用后必须在限定时间内用完。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#fefff8 75%,#f9f3f5 100%);\">\n    \u003Ch2 class=\"material-subtitle\">05. 剂型选择与不同服药技巧 🧪\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>片剂：\u003C/strong>不可掰开或嚼碎服用，避免影响药效。如遇吞咽困难应联系医生调整剂型。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射剂：\u003C/strong>严禁自行注射，所有化疗/靶向注射需专业医疗团队完成，注射时需核对药品批号、剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>口服用药饮水量：\u003C/strong>口服片剂或胶囊时须配足量温开水（约200-300ml），减少药物在食道停留时间，降低刺激风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>使用场景小结：\u003C/strong>\n          化疗药物推荐餐前、经医嘱调整；内分泌药物餐后服用可减少胃肠不适；靶向药物按方案安排，切忌随意变更。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#f7faf6 65%,#f1f0fa 100%);\">\n    \u003Ch2 class=\"material-subtitle\">06. 不良反应的识别与处置 🚩\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>化疗药物：\u003C/strong>可能出现恶心呕吐、脱发、血常规异常等。轻微不适时适量休息，若出现持续高烧或感染征象需立即就医。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>内分泌药物：\u003C/strong>潮热、情绪波动、关节疼痛为常见表现。对症处理或简化日常活动可有效缓解多数症状。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>靶向药物：\u003C/strong>极少数人可能心脏不适或轻微过敏反应，注射期间如有胸闷、呼吸急促应告知医护人员。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>常见数据提示：\u003C/strong>文献报道，多柔比星相关心脏毒性发生率约 5-8%（Hershman DL et al., 2008）；内分泌药物关节痛发生率约 20-25%（Witzel I et al., 2014）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>实际用药案例：\u003C/strong>\n          一位患者接受紫杉醇后反应性骨髓抑制，通过短期调整给药周期及加强监测，未影响整体用药计划。提示按方案评估及动态随访不可或缺。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#fefeff 90%,#f7f4fa 100%);\">\n    \u003Ch2 class=\"material-subtitle\">07. 用药禁忌、特殊人群与合理避险🛡️\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>妊娠与哺乳：\u003C/strong>绝大多数化疗和靶向药物孕期禁用，哺乳期间亦需中止有关药品，尤其是多柔比星、环磷酰胺等。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能异常：\u003C/strong>重度肝肾功能损伤时需调整剂量，有些药物甚至需中止，具体调整应由医生操作。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>老年患者：\u003C/strong>对化疗药物更为敏感，不良反应风险高，应酌情减量或延长期限，定期随访血常规及心功能。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药物过敏史：\u003C/strong>曾有严重药物过敏反应者，所有新药启动前需全程医学监护。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>特殊提醒：\u003C/strong>一旦出现不适或可疑反应，切勿自行停药/换药，须与专业医生沟通，绝不盲目调整方案。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#e7f3f5 40%,#f9fcf1 100%);\">\n    \u003Ch2 class=\"material-subtitle\">08. 药品储存与过期提示 🗃️\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>片剂、胶囊：\u003C/strong>放在干燥阴凉处（25°C以下），勿让儿童接触。部分药品开瓶后保质期为1-3个月，应依据包装说明。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射剂：\u003C/strong>多为冷藏保存（2-8°C），启用后需限时用完，切忌反复暴露于空气中。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过期药品：\u003C/strong>变色、起斑或气味异常时不可再用，过期药按正规药品回收渠道处理，切勿随意丢弃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>补充细节：\u003C/strong>易受潮或光敏感的内分泌药物务必密封存放，如发现外观异常应及时更换。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background:linear-gradient(90deg,#faede8 40%,#eaf6fd 100%);\">\n    \u003Ch2 class=\"material-subtitle\">09. 药物漏服与过量怎么办？🔔\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>\n          \u003Cstrong>漏服：\u003C/strong>以口服内分泌药物为例，如未及时服用发现后6小时内可补服，超过则略过，当天余下药物勿双倍补用，第二天按普通方案继续。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过量处理：\u003C/strong>大量口服或误用需立刻就医，辅助化疗、靶向注射药物切勿自行为补救处置。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>临床数据：\u003C/strong>说明书提示，他莫昔芬过量服用可能导致视觉障碍、步态异常等，需紧急处理（Jordan VC, et al., 2006）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>全天候建议：\u003C/strong>保持药盒、服药记录，尽量安排固定服药时间，有家属参与监控更为保险。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-summary\" style=\"background:linear-gradient(90deg,#f1f7fb 50%,#f9f2fa 100%);\">\n    \u003Ch2 class=\"material-subtitle\">10. 重点回顾与实践建议 💡\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      乳腺癌 pT2N0M0 治疗常用药品涵盖化疗、内分泌和靶向三大类别。各药物操作方式和注意事项略有不同，但都有统一原则：\u003Cstrong>严格遵医嘱，别擅自加减剂量\u003C/strong>。\u003Cbr>\n      \u003Cbr>\n      化疗药品强调周期和监护，内分泌药品重视持续性与规律服用，靶向药物需警惕特殊副作用和心脏风险。所有药物存放有明确温度和密封要求，同时需警惕漏服和过量风险。\u003Cbr>\n      \u003Cbr>\n      最后再次强调：任何用药疑问和不良反应\u003Cbr>\u003Cspan class=\"material-warning\">务必第一时间联系医生\u003C/span>，确保疗效和安全两手抓。忘记了细节？随时翻查本指南，随手做到安全用药，帮助自己和家人规避风险！🍀\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\">\n    \u003Ch2 class=\"material-ref-title\">主要参考文献\u003C/h2>\n    \u003Cul class=\"material-ref-list\">\n      \u003Cli>Hershman DL, et al. \"Anthracyclines and Risk of Heart Failure in Breast Cancer Patients.\" \u003Cem>J Natl Cancer Inst\u003C/em>, 2008;100(14):1042-1049.\u003C/li>\n      \u003Cli>Witzel I, et al. \"Adverse effects of endocrine therapy in breast cancer: a cross-sectional study.\" \u003Cem>J Cancer Res Clin Oncol\u003C/em>, 2014;140(10):1707-1715.\u003C/li>\n      \u003Cli>Jordan VC, et al. \"Pharmacology of tamoxifen in the treatment of breast cancer.\" \u003Cem>The J Clin Pharmacol\u003C/em>, 2006;46(9):1028-1051.\u003C/li>\n      \u003Cli>Slamon DJ, et al. \"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.\" \u003Cem>N Engl J Med\u003C/em>, 2001;344(11):783-792.\u003C/li>\n      \u003Cli>Early Breast Cancer Trialists' Collaborative Group (EBCTCG). \"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.\" \u003Cem>The Lancet\u003C/em>, 2015;386(10001):1341-1352.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-guide {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  color: #252237;\n  background: #fcff;\n  max-width: 940px;\n  margin: 0 auto;\n  padding: 36px 30px 60px 30px;\n  border-radius: 12px;\n  box-shadow: 0 8px 32px rgba(80,70,120,0.12);\n  letter-spacing: .03em;\n  line-height: 1.85;\n}\n.material-title {\n  font-weight: 700;\n  font-size: 2.1em;\n  line-height: 1.3;\n  margin-bottom: 34px;\n  position: relative;\n  color: #35447f;\n  text-shadow: 0 2px 8px rgba(180,180,220,0.05);\n  letter-spacing: .06em;\n  border-left: 7px solid #97b0fc;\n  padding-left: 22px;\n}\n.material-section {\n  padding: 25px 34px 22px 34px;\n  border-radius: 16px;\n  margin-bottom: 32px;\n  box-sizing: border-box;\n}\n.material-subtitle {\n  font-size: 1.42em;\n  color: #615d85;\n  font-weight: 600;\n  margin: 0 0 15px 0;\n  letter-spacing: .04em;\n  display: flex;\n  align-items: center;\n  gap: 10px;\n}\n.material-content {\n  font-size: 1em;\n}\n.material-list {\n  padding-left: 18px;\n  margin: 0;\n  list-style: none;\n}\n.material-list li {\n  margin: 0 0 16px 0;\n  padding-left: 6px;\n  line-height: 1.95;\n  position: relative;\n}\n.material-list li strong {\n  color: #394b91;\n  font-weight: 600;\n}\n.material-list li:before {\n  content: \"•\";\n  color: #c1c8fd;\n  margin-right: 10px;\n  font-size: 1.1em;\n  position: absolute;\n  left: -18px;\n  top: 2px;\n}\n.material-summary {\n  border-left: 7px solid #97b0fc;\n  background:linear-gradient(90deg,#f1f7fb 55%,#fffcfe 100%);\n}\n.material-warning {\n  background: #fff4e4;\n  color: #cd6536;\n  border-radius: 7px;\n  padding: 2px 9px;\n  font-weight: bold;\n  margin-left: 3px;\n}\n.material-ref-title {\n  font-size: 1.15em;\n  margin-top: 0;\n  margin-bottom: 10px;\n  color: #5d659c;\n  font-weight: 600;\n  letter-spacing: .02em;\n}\n.material-ref-list {\n  margin: 0;\n  padding-left: 20px;\n  font-size: 0.98em;\n  color: #878bb5;\n}\n.material-ref-list li {\n  margin-bottom: 7px;\n  line-height: 1.6;\n  word-break: break-all;\n}\n@media(max-width:700px) {\n  .material-guide {\n    max-width: 98%;\n    padding: 18px 6px 25px 6px;\n    font-size: 1em;\n  }\n  .material-section {\n    padding: 16px 10px 13px 10px;\n    border-radius: 12px;\n  }\n  .material-title {\n    font-size: 1.18em;\n    padding-left: 13px;\n    margin-bottom: 19px;\n  }\n  .material-subtitle {\n    font-size: 1em;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"material-guide\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">乳腺癌 pT2N0M0 治疗方案常用药品：安",512,"2025-11-25 03:25:32","乳腺癌, pT2N0M0, 化疗, 内分泌治疗, 靶向治疗","本文全面解析乳腺癌 pT2N0M0 常用药品的使用方法与注意事项，帮助患者了解化疗、内分泌和靶向治疗药物的安全用药细节，解答患者用药过程中的常见疑惑。","2025-11-28 16:30:02",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]